KP Tissue Inc., a prominent player in the tissue product manufacturing industry, has delivered strong financial results for the second quarter of 2024. The company reported an impressive 18.6% increase in adjusted EBITDA, reaching $65.3 million. This growth is primarily attributed to higher sales volumes, a favorable sales mix, and enhanced pricing strategies. Additionally, KP Tissue's revenue received a boost from a favorable foreign exchange impact and increased sales in both the US and Canadian markets.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
